Drug · DIN 02520834
ZEPZELCA
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since June 17, 2026; first marketed December 6, 2021.
- Drug Identification Number (DIN)
- 02520834
- Company (DIN owner)
- Jazz Pharmaceuticals Ireland LimitedDublin, Dublin, Ireland
- Schedule
- Prescription
- Dosage form
- Powder
- Route
- Intravenous
- Therapeutic class (ATC)
- Lurbinectedin L01XX69
- Class
- Human
- Record last updated
- July 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LURBINECTEDIN | 4 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2021: NOC 26751New Drug Submission (NDS)